Stay updated on Acalabrutinib vs Ibrutinib in CLL Clinical Trial

Sign up to get notified when there's something new on the Acalabrutinib vs Ibrutinib in CLL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Acalabrutinib vs Ibrutinib in CLL Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    A general NIH website-transition notice appears above the ClinicalTrials.gov error page.
    Difference
    1%
    Check dated 2026-10-25T01:39:22.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer now displays revision v3.7.2 instead of v3.7.1. The page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T01:20:40.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page’s footer revision identifier changed from v3.7.0 to v3.7.1 while the page continued to show a 403 error.
    Difference
    0.2%
    Check dated 2026-10-11T01:52:51.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, indicating that access to the study record is blocked. The UI includes a 403 header and a Home button, signaling an access restriction rather than study content.
    Difference
    17%
    Check dated 2026-09-20T00:57:57.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    Tel Litwinsky, Israel, 52621 was added as a recruitment site, and Qiryat Krinitzi, Israel, 52621 was removed.
    Difference
    0.0%
    Check dated 2026-09-13T00:10:56.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    Israel-based enrollment site Tel Litwinsky, 52621 was removed and a new site, Qiryat Krinitzi, 52621, Israel, was added to the study's location list. This reflects an update to the listed trial sites in Israel, changing where participants in that country can enroll.
    Difference
    0.0%
    Check dated 2026-09-05T22:58:17.000Z thumbnail image

Stay in the know with updates to Acalabrutinib vs Ibrutinib in CLL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Acalabrutinib vs Ibrutinib in CLL Clinical Trial page.